🚧Website under construction—New articles and features coming soon
🔬 Students & Researchers

Meet the nano-sized particles behind probiotics' effects

The emerging science of probiotic mechanisms — and why extracellular vesicles might be their most powerful tool

By Cecilia L. D'Antoni, PhD in Biological Chemistry•March 2026•7 min read

Specialist in probiotic microencapsulation, extracellular vesicles and gut microbiome biology

What are EVs?

Nearly all living cells—from the bacteria in your gut to the cells in your brain—release Extracellular Vesicles (EVs). Think of an EV as a biological shipping container. Instead of a cell releasing individual proteins or signals that might get lost or broken down, it packs them into a spherical shell made of lipids (fats). Inside these packages, relies a concentrated personalised "message" consisting of proteins, DNA, RNA, and metabolites (Welsh et al. 2024).

For decades, EVs were dismissed as cellular "garbage". Today, we know they are sophisticated messengers with a vital mission: to travel to a target cell, merge with its membrane, and "upload" the cargo to change that cell's behavior.

What are Probiotic-derived EVs?

Probiotic-derived EVs are nano-sized particles (generally between 20 and 400 nm) secreted by beneficial bacterial species like Lactobacillus, Bifidobacterium, and Akkermansia (Zhang et al. 2025). These EVs usually maintain a similar functional activity as the live probiotic they came from, but in a much more mobile format. The clinical evidence for these effects comes from RCTs and meta-analyses indexed in PubMed, systematic reviews in Cochrane, and studies registered on ClinicalTrials.gov.

The "Shield" and the "Fantastic Voyage"

One of the most remarkable features of EVs is their ability to survive a "fantastic voyage" through the human body (Stentz et al. 2018).

  • •A Natural Armor: The bilayer lipid membrane of these EVs acts as sophisticated armor, protecting their cargo from degradation in the hostile physiological environment.
  • •Crossing Barriers: Unlike live probiotics, which struggle to reach distant sites, their nano-sized derived EVs use specialized routes to cross the intestinal epithelium:
  • –Transcellular and Paracellular Transmigration: They can move directly through cells or pass between them.
  • –Escaping Degradation: While most particles are broken down by lysosomes, EVs can use caveolin-mediated endocytosis. This allows them to bypass the cell's "shredder" and deliver their cargo safely to the endoplasmic reticulum or Golgi complex.

Why are they a "Super Tool"?

Apart from protecting their cargo, and traversing biological barriers, the potency of probiotic-derived EVs lies in their ability to mediate communication between bacteria and host cells. Crucially, this isn't just true for probiotics; it applies to our entire resident microbiome. These nano-sized "packages" allow our gut bacteria to influence our health from a distance (DomĂ­nguez Rubio et al. 2022; Zhang et al. 2025).

  1. 1.
    Systemic Distribution: Once they cross the intestinal barrier, EVs enter the bloodstream and lymphatic system. They can be detected in the blood (a phenomenon called DNAemia) and even in urine, serving as a snapshot of gut health.
  2. 2.
    Reaching Distal Frontiers: Due to their size, they can cross the blood-brain barrier and the placental barrier.
    • • In the brain, they can reduce neuroinflammation.
    • • During pregnancy, vesicles from bacteria like Akkermansia muciniphila can reach the fetus to reduce oxidative stress.
  3. 3.
    Superior Safety: As non-living components, probiotic-derived EVs eliminate the risk of sepsis. This makes them ideal for vulnerable populations like premature neonates or immunocompromised patients.

Mechanisms: How They Modulate Health

Science identifies three primary ways these nanoparticles interact with the host:

  • •Immune Modulation: PEVs interact with receptors like TLR2 and NOD1. For example, vesicles from Bifidobacterium bifidum induce the differentiation of Treg cells, promoting immune tolerance and reducing inflammation.
  • •Reinforcing the Gut Barrier: Vesicles from A. muciniphila and E. coli Nissle 1917 activate "tight junction" proteins (like Occludin and ZO-1), repairing the physical seal of the gut.
  • •Pathogen Inhibition: Probiotic-derived EVs carry natural antibiotics (bacteriocins) to attack invaders and can even physically block viruses, such as HIV-1, from attaching to human cells.

Future Applications: Beyond Nutrition

Probiotic-derived EVs are being explored as high-tech drug delivery platforms. Additionally, since they are generally biocompatible and "decorated" with molecular patterns that the immune system recognizes, they are ideal candidates for mucosal vaccines. They act as natural adjuvants, safely triggering protective antibodies (like IgA) without the dangers of using live pathogens.

About the author

Cecilia L. D'Antoni holds a PhD in Biological Chemistry from the University of Buenos Aires, where she specialised in probiotic bacteria, extracellular vesicles and microencapsulation.

References

DomĂ­nguez Rubio AP, D'Antoni CL, Piuri M, PĂ©rez OE (2022) Probiotics, Their Extracellular Vesicles and Infectious Diseases. Front. Microbiol. 13. doi: 10.3389/fmicb.2022.864720

Stentz R, Carvalho AL, Jones EJ, Carding SR (2018) Fantastic voyage: The journey of intestinal microbiota-derived microvesicles through the body. Biochem. Soc. Trans. 46:1021–1027. doi: 10.1042/BST20180114

Welsh JA, Goberdhan DCI, O'Driscoll L, et al (2024) Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles 13:. https://doi.org/10.1002/jev2.12404

Zhang X, Wang Y, E Q, et al (2025) The biological activity and potential of probiotics-derived extracellular vesicles as postbiotics in modulating microbiota-host communication. Journal of Nanobiotechnology. doi: 10.1186/s12951-025-03435-6.